Tetrandrine targeting SIRT5 exerts anti-melanoma properties via inducing ROS,ER stress,and blocked autophagy
10.1016/j.jpha.2024.101036
- Author:
Ji YACONG
1
,
2
;
Li CHONGYANG
;
Wan SICHENG
;
Dong ZHEN
;
Liu CHAOLONG
;
Guo LEIYANG
;
Shi SHAOMIN
;
Ci MINGXIN
;
Xu MINGHAO
;
Li QIAN
;
Hu HUANRONG
;
Cui HONGJUAN
;
Liu YALING
Author Information
1. Department of Dermatology,The Third Hospital of Hebei Medical University,Shijiazhuang,050051,China
2. State Key Laboratory of Resource Insects,Medical Research Institute,Southwest University,Chongqing,400715,China
- Keywords:
Melanoma;
Tetrandrine;
Sirtuin 5(SIRT5);
Mitophagy;
Cytoskeletal protein depolymerization;
Reactive oxygen species(ROS)
- From:
Journal of Pharmaceutical Analysis
2024;14(10):1468-1483
- CountryChina
- Language:Chinese
-
Abstract:
Tetrandrine(TET),a natural bisbenzyl isoquinoline alkaloid extracted from Stephania tetrandra S.Moore,has diverse pharmacological effects.However,its effects on melanoma remain unclear.Cellular prolif-eration assays,multi-omics analyses,and xenograft models were used to determine the effect of TET on melanoma.The direct target of TET was identified using biotin-TET pull-down liquid chromatograph-mass spectrometry(LC-MS),cellular thermal shift assays,and isothermal titration calorimetry(ITC)analysis.Our findings revealed that TET treatment induced robust cellular autophagy depending on activating transcription factor 6(ATF6)-mediated endoplasmic reticulum(ER)stress.Simultaneously,it hindered autophagic flux by inducing cytoskeletal protein depolymerization in melanoma cells.TET treatment resulted in excessive accumulation of reactive oxygen species(ROS)and simultaneously triggered mitophagy.Sirtuin 5(SIRT5)was ultimately found to be a direct target of TET.Mechanistically,TET led to the degradation of SIRT5 via the ubiquitin(Ub)-26S proteasome system.SIRT5 knockdown induced ROS accumulation,whereas SIRT5 overexpression attenuated the TET-induced ROS accumula-tion and autophagy.Importantly,TET exhibited anti-cancer effects in xenograft models depending on SIRT5 expression.This study highlights the potential of TET as an antimelanoma agent that targets SIRT5.These findings provide a promising avenue for the use of TET in melanoma treatment and underscore its potential as a therapeutic candidate.
